Cwa Asset Management Group, LLC Amgen Inc Transaction History

Cwa Asset Management Group, LLC

$2.27 Billion
Q2 2025

A detailed history of Cwa Asset Management Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Cwa Asset Management Group, LLC holds 21,347 shares of AMGN stock, worth $6.54 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

21,347

Previous 22,974 7.08%

Holding current value

$6.54 Million

Previous $7.16 Million 16.72%

% of portfolio

0.26%

Previous 0.35%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 17, 2025	SELL	$262.28 - $309.85 $426,729 - $504,125	-1,627 Reduced 7.08%	21,347 $5.96 Million
Q1 2025 Apr 21, 2025	BUY	$258.59 - $327.36 $4.34 Million - $5.49 Million	16,776 Added 270.67%	22,974 $7.16 Million
Q4 2024 Jan 06, 2025	BUY	$258.78 - $328.31 $223,327 - $283,331	863 Added 16.18%	6,198 $1.62 Million
Q3 2024 Nov 01, 2024	BUY	$309.38 - $337.38 $303,811 - $331,307	982 Added 22.56%	5,335 $1.72 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $431,805 - $521,243	1,606 Added 58.46%	4,353 $1.24 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $105,604 - $119,133	413 Added 17.69%	2,747 $791,000
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $108,231 - $134,372	495 Added 26.92%	2,334 $627,000
Q2 2023 Jul 27, 2023	SELL	$214.27 - $253.37 $69,852 - $82,598	-326 Reduced 15.06%	1,839 $408,000
Q1 2023 Apr 17, 2023	BUY	$225.79 - $275.2 $140,215 - $170,899	621 Added 40.22%	2,165 $523,000
Q4 2022 Jan 09, 2023	BUY	$229.03 - $291.01 $107,415 - $136,483	469 Added 43.63%	1,544 $0
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $31,648 - $35,694	-141 Reduced 11.6%	1,075 $242,000
Q2 2022 Jul 21, 2022	BUY	$230.71 - $256.74 $58,831 - $65,468	255 Added 26.53%	1,216 $296,000
Q1 2022 Apr 21, 2022	BUY	$219.27 - $242.57 $210,718 - $233,109	961 New	961 $232,000
Q4 2021 Feb 15, 2022	SELL	$198.88 - $227.6 $583,513 - $667,778	-2,934 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $16,769 - $19,647	-79 Reduced 2.62%	2,934 $624,000
Q2 2021 Aug 03, 2021	BUY	$233.58 - $259.14 $171,214 - $189,949	733 Added 32.15%	3,013 $744,000
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $6,879 - $8,016	-31 Reduced 1.34%	2,280 $567,000
Q4 2020 Feb 23, 2021	BUY	$216.38 - $257.67 $90,879 - $108,221	420 Added 22.21%	2,311 $531,000
Q4 2020 Feb 09, 2021	SELL	$216.38 - $257.67 $92,177 - $109,767	-426 Reduced 18.39%	1,891 $435,000
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $18,772 - $20,876	80 Added 3.58%	2,317 $589,000
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $34,814 - $42,722	-176 Reduced 7.29%	2,237 $528,000
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $31,163 - $41,330	171 Added 7.63%	2,413 $489,000
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $31,598 - $40,614	-167 Reduced 6.93%	2,242 $540,000
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $3.22 Million - $3.86 Million	-18,522 Reduced 88.49%	2,409 $466,000
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $95,019 - $111,383	570 Added 2.8%	20,931 $3.86 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $239,833 - $270,344	-1,326 Reduced 6.11%	20,361 $3.87 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $105,612 - $123,284	592 Added 2.81%	21,687 $4.22 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $23,531 - $26,529	-127 Reduced 0.6%	21,095 $4.37 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $145,791 - $163,755	878 Added 4.32%	21,222 $3.92 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $472,201 - $551,826	2,787 Added 15.87%	20,344 $3.47 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $172,672 - $192,927	1,023 Added 6.19%	17,557 $3.05 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $195,060 - $222,706	1,166 Added 7.59%	16,534 $3.08 Million
Q2 2017 Aug 10, 2017	BUY	N/A	15,368	15,368 $2.65 Million

Others Institutions Holding AMGN

# of Institutions

3,285

Shares Held

426M

Call Options Held

8.07M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $164B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwa Asset Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwa Asset Management Group, LLC with notifications on news.

Account

Cwa Asset Management Group, LLC Amgen Inc Transaction History